Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7936)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2015 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Gao S, Zhang PJ, Guo JH, Chen H, Xu HF, Liu P, Yang RJ, Zhu X. Chemoembolization alone |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i36/10443.htm |
| Number | Citing Articles |
| 1 |
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Xin Zhang, Hui Chen, Xiao-Dong Wang, Ren-Jie Yang. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2020; 12(6): 663-676 doi: 10.4251/wjgo.v12.i6.663
|
| 2 |
Binkui Li, Jiliang Qiu, Yun Zheng, Yunxing Shi, Ruhai Zou, Wei He, Yichuang Yuan, Yuanping Zhang, Chenwei Wang, Zhiyu Qiu, Kai Li, Chengrui Zhong, Yunfei Yuan. Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma. Annals of Surgery Open 2021; 2(2): e057 doi: 10.1097/AS9.0000000000000057
|
| 3 |
Baojiang Liu, Song Gao, Jianhai Guo, Fuxin Kou, Shaoxing Liu, Xin Zhang, Xiaodong Wang, Guang Cao, Hui Chen, Peng Liu, Haifeng Xu, Qinzong Gao, Renjie Yang, Xu Zhu. A Novel Nomogram for Predicting the Overall Survival in Patients with Unresectable HCC after TACE plus Hepatic Arterial Infusion Chemotherapy. Translational Oncology 2023; 34: 101705 doi: 10.1016/j.tranon.2023.101705
|
| 4 |
Baojiang Liu, Song Gao, Jianhai Guo, Fuxin Kou, Shaoxing Liu, Xin Zhang, Aiwei Feng, Xiaodong Wang, Guang Cao, Hui Chen, Peng Liu, Haifeng Xu, Qinzong Gao, Renjie Yang, Liang Xu, Xu Zhu. Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 477 doi: 10.2147/JHC.S452120
|
| 5 |
Jian-Hai Guo, Shao-Xing Liu, Song Gao, Fu-Xin Kou, Xin Zhang, Di Wu, Xiao-Ting Li, Hui Chen, Xiao-Dong Wang, Peng Liu, Peng-Jun Zhang, Hai-Feng Xu, Guang Cao, Lin-Zhong Zhu, Ren-Jie Yang, Xu Zhu. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(27): 3975-3988 doi: 10.3748/wjg.v26.i27.3975
|
| 6 |
Jingjun Huang, Wensou Huang, Meixiao Zhan, Yongjian Guo, Licong Liang, Mingyue Cai, Liteng Lin, Mingji He, Hui Lian, Ligong Lu, Kangshun Zhu. Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; : 1445 doi: 10.2147/JHC.S339379
|
| 7 |
Shengli Mi, Jingjing Xia, Yuanyuan Xu, Zhichang Du, Wei Sun. An integrated microchannel biosensor platform to analyse low density lactate metabolism in HepG2 cells in vitro. RSC Advances 2019; 9(16): 9006 doi: 10.1039/C9RA00694J
|
| 8 |
Baojiang Liu, Xu Zhu, Song Gao, Jianhai Guo, Xiaodong Wang, Guang Cao, Linzhong Zhu, Peng Liu, Haifeng Xu, Hui Chen, Xin Zhang, Shaoxing Liu, Fuxin Kou. Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma. Journal of Interventional Medicine 2019; 2(2): 91 doi: 10.1016/j.jimed.2019.07.006
|
| 9 |
|
| 10 |
Jingjing Sha, Yunpeng Bai, Huy Xuan Ngo, Tatsuo Okui, Takahiro Kanno. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition. Biomolecules 2021; 11(6): 893 doi: 10.3390/biom11060893
|
| 11 |
Guan-Bao Long, Chao-Wen Xiao, Xin-Yang Zhao, Jun Zhang, Xin Li. Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma. Medicine 2020; 99(26): e20745 doi: 10.1097/MD.0000000000020745
|
| 12 |
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Fu-Xin Kou, Shao-Xing Liu, Xin Zhang, Xiao-Dong Wang, Guang Cao, Hui Chen, Peng Liu, Hai-Feng Xu, Qin-Zong Gao, Ren-Jie Yang. Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors for advanced hepatocellular carcinoma. Immunotherapy 2021; 13(17): 1395 doi: 10.2217/imt-2021-0192
|
| 13 |
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Fu-Xin Kou, Shao-Xing Liu, Xin Zhang, Xiao-Dong Wang, Guang Cao, Hui Chen, Peng Liu, Lin-Zhong Zhu, Hai-Feng Xu, Ren-Jie Yang, Rong Liu. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6670367
|
| 14 |
Song Chen, Feng Shi, Zhiqiang Wu, Liguang Wang, Hongjie Cai, Ping Ma, Yuanmin Zhou, Qicong Mai, Fan Wang, Shuangyan Tang, Wenquan Zhuang, Jiaming Lai, Xiaoming Chen, Huanwei Chen, Wenbo Guo. Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study. Journal of Hepatocellular Carcinoma 2023; : 1209 doi: 10.2147/JHC.S417550
|
| 15 |
Xiaoni Liu, Jianji Xu, Shuang Wang, Xiaoxiao Yu, Boxin Kou, Mengyin Chai, Yunjin Zang, Dexi Chen. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo. International Journal of Oncology 2017; 51(4): 1291 doi: 10.3892/ijo.2017.4105
|
| 16 |
Jian-Hai Guo, Shao-Xing Liu, Song Gao, Fu-Xin Kou, Xin Zhang, Di Wu, Xiao-Ting Li, Hui Chen, Xiao-Dong Wang, Peng Liu, Peng-Jun Zhang, Hai-Feng Xu, Guang Cao, Lin-Zhong Zhu, Ren-Jie Yang, Xu Zhu. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(27): 3971 doi: 10.3748/wjg.v26.i27.3971
|
| 17 |
Ahlim Lee, Jaejun Lee, Hyun Yang, Soo-Yoon Sung, Chang Ho Jeon, Su Ho Kim, Moon Hyung Choi, Young Joon Lee, Ho Jong Chun, Si Hyun Bae. Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma. Journal of Liver Cancer 2022; 22(1): 75 doi: 10.17998/jlc.2022.03.04
|
| 18 |
Fundamentals of Cancer Detection, Treatment, and Prevention. 2022; : 247 doi: 10.1002/9783527838561.ch10
|